Idiopathic intracranial hypertension

被引:72
|
作者
Dhungana, S. [1 ]
Sharrack, B. [1 ]
Woodroofe, N. [2 ]
机构
[1] Univ Sheffield, Sheffield Teaching Hosp NHS Trust, Sheffield, S Yorkshire, England
[2] Sheffield Hallam Univ, Sheffield S1 1WB, S Yorkshire, England
来源
ACTA NEUROLOGICA SCANDINAVICA | 2010年 / 121卷 / 02期
关键词
idiopathic intracranial hypertension; review; pathogenesis; SYSTEMIC LUPUS-ERYTHEMATOSUS; PSEUDOTUMOR CEREBRI SYNDROME; CEREBROSPINAL-FLUID DIVERSION; NERVE SHEATH DECOMPRESSION; TRANSVERSE SINUS STENOSES; POLYCYSTIC-OVARY-SYNDROME; L-THYROXINE THERAPY; INDUCED WEIGHT-LOSS; MR VENOGRAPHY; TUMOR CEREBRI;
D O I
10.1111/j.1600-0404.2009.01172.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Idiopathic intracranial hypertension (IIH) is a condition which affects predominantly overweight women and is characterized by raised intracranial pressure without any identifiable pathology in the brain and with normal cerebrospinal fluid (CSF) composition. The cause of IIH is unclear and as such it remains a diagnosis of exclusion. Although the pathophysiology of IIH remains elusive, some observations have recently been added to our understanding of this, including the presence of transverse sinus stenosis on many patients and the possible role of leptin and inflammation in the disease pathogenesis. Headache is the most common symptom and papilloedema is the major clinical finding. Choices of medical treatment are limited to the use of diuretics particularly acetazolamide and encouragement of weight loss. Surgical therapies such as CSF diversion procedures and fenestration of the optic nerve may be necessary in some cases with persistent symptoms or progressive visual deterioration. While not life-threatening, IIH has a significant morbidity with up to 25% of patients developing visual impairment from optic atrophy. Visual surveillance is therefore vital. Long-term follow-up is recommended as the disease may worsen after an initial period of stability.
引用
收藏
页码:71 / 82
页数:12
相关论文
共 50 条
  • [1] Idiopathic Intracranial Hypertension and the Idiopathic Intracranial Hypertension Treatment Trial
    Wall, Michael
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2013, 33 (01) : 1 - 3
  • [2] Idiopathic Intracranial Hypertension Without Intracranial Hypertension
    Sansone, Mattia
    De Angelis, Michelangelo
    Bilo, Leonilda
    Bonavita, Vincenzo
    De Simone, Roberto
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (03) : E350 - E352
  • [3] Idiopathic intracranial hypertension
    Digre, Kathleen B.
    [J]. BRITISH MEDICAL JOURNAL, 2010, 341
  • [4] Idiopathic intracranial hypertension
    Morrish, Paul
    [J]. CLINICAL MEDICINE, 2020, 20 (05) : E138 - E138
  • [5] IDIOPATHIC INTRACRANIAL HYPERTENSION
    RADHAKRISHNAN, K
    AHLSKOG, JE
    GARRITY, JA
    KURLAND, LT
    [J]. MAYO CLINIC PROCEEDINGS, 1994, 69 (02) : 169 - 180
  • [6] Idiopathic intracranial hypertension
    Kathleen B. Digre
    [J]. Current Treatment Options in Neurology, 1999, 1 (1) : 74 - 81
  • [7] Idiopathic intracranial hypertension
    Farmen, Anette Huuse
    Ringstad, Geir
    Kerty, Emilia
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (22) : 1895 - 1898
  • [8] IDIOPATHIC INTRACRANIAL HYPERTENSION
    WALL, M
    [J]. NEUROLOGIC CLINICS, 1991, 9 (01) : 73 - 95
  • [9] Idiopathic intracranial hypertension
    Mears, Katrina A.
    Van Stavern, Gregory P.
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2012, 7 (05) : 487 - 498
  • [10] Idiopathic intracranial Hypertension
    Baeuerle, J.
    Egger, K.
    Harloff, A.
    [J]. NERVENARZT, 2017, 88 (02): : 191 - 200